Analysis of membrane interactions of antibiotic peptides using ITC and biosensor measurements

被引:21
作者
Al-Kaddah, Saad [1 ]
Reder-Christ, Katrin [1 ]
Klocek, Gabriela [2 ]
Wiedemann, Imke [3 ]
Brunschweiger, Manuela [1 ]
Bendas, Gerc [1 ]
机构
[1] Univ Bonn, Dept Pharm, D-53121 Bonn, Germany
[2] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland
[3] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Unit, D-53115 Bonn, Germany
关键词
Antibiotics; Gallidermin; Isothermal titration calorimetry (ITC); Lipid II; Surface acoustic wave (SAW) biosensor; Vancomycin; LIPID-II; CELL-WALL; PEPTIDOGLYCAN BIOSYNTHESIS; ANTIMICROBIAL PEPTIDES; TITRATION CALORIMETRY; PORE FORMATION; NISIN; BINDING; VANCOMYCIN; MODE;
D O I
10.1016/j.bpc.2010.09.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of the lantibiotic gallidermin and the glycopeptide antibiotic vancomycin with bacterial membranes was simulated using mass sensitive biosensors and isothermal titration calorimetry (ITC). Both peptides interfere with cell wall biosynthesis by targeting the cell wall precursor lipid II, but differ clearly in their antibiotic activity against individual bacterial strains. We determined the binding affinities of vancomycin and gallidermin to model membranes +/- lipid II in detail. Both peptides bind to DOPC/lipid II membranes with high affinity (K-D 0.30 mu M and 0.27 mu M). Gallidermin displayed also strong affinity to pure DOPC membranes (0.53 mu M)an effect that was supported by ITC measurements. A surface acoustic wave (SAW) sensor allowed measurements in the picomolar concentration range and revealed that gallidermin targets lipid II at an equimolar ratio and simultaneously inserts into the bilayer. These results indicate that gallidermin, in contrast to vancomycin, combines cell wall inhibition and interference with the bacterial membrane integrity for potent antimicrobial activity. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 39 条
[1]  
AMES BN, 1960, J BIOL CHEM, V235, P769
[2]   Surface acoustic wave biosensor as a tool to study the interaction of antimicrobial peptides with phospholipid and lipopolysaccharide model membranes [J].
Andrae, Joerg ;
Boehling, Arne ;
Gronewold, Thomas M. A. ;
Schlecht, Ulrich ;
Perpeet, Markus ;
Gutsmann, Thomas .
LANGMUIR, 2008, 24 (16) :9148-9153
[3]   Enhanced membrane pore formation by Multimeric/Oligomeric antimicrobial peptides [J].
Arnusch, Christopher J. ;
Branderhorst, Hilbert ;
De Kruijff, Ben ;
Liskamp, Rob M. J. ;
Breukink, Eefjan ;
Pieters, Roland J. .
BIOCHEMISTRY, 2007, 46 (46) :13437-13442
[4]   DIMERIZATION AND MEMBRANE ANCHORS IN EXTRACELLULAR TARGETING OF VANCOMYCIN GROUP ANTIBIOTICS [J].
BEAUREGARD, DA ;
WILLIAMS, DH ;
GWYNN, MN ;
KNOWLES, DJC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :781-785
[5]   Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes [J].
Binder, H ;
Lindblom, G .
BIOPHYSICAL JOURNAL, 2003, 85 (02) :982-995
[6]   Influence of Ca2+ Ions on the Activity of Lantibiotics Containing a Mersacidin-Like Lipid II Binding Motif [J].
Boettiger, T. ;
Schneider, T. ;
Martinez, B. ;
Sahl, H. -G. ;
Wiedemann, I. .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2009, 75 (13) :4427-4434
[7]   Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies [J].
Bonelli, RR ;
Schneider, T ;
Sahl, HG ;
Wiedemann, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1449-1457
[8]   Binding of nisin Z to bilayer vesicles as determined with isothermal titration calorimetry [J].
Breukink, E ;
Ganz, P ;
de Kruijff, B ;
Seelig, J .
BIOCHEMISTRY, 2000, 39 (33) :10247-10254
[9]   Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes [J].
Breukink, E ;
van Heusden, HE ;
Vollmerhaus, PJ ;
Swiezewska, E ;
Brunner, L ;
Walker, S ;
Heck, AJR ;
de Kruijff, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (22) :19898-19903
[10]   Lipid II as a target for antibiotics [J].
Breukink, E ;
de Kruijff, B .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (04) :321-332